 | Up a level |
Rajeev, S, Sprung, VS 
ORCID: 0000-0002-2666-4986, Roberts, C ORCID: 0000-0003-4275-601X, Harrold, JA ORCID: 0000-0002-0899-4586, Halford, JCG ORCID: 0000-0003-1629-3189, Stancak, A ORCID: 0000-0003-3323-3305, Boyland, E ORCID: 0000-0001-8384-4994, Kemp, GJ ORCID: 0000-0002-8324-9666, Cuthbertson, D ORCID: 0000-0002-6128-0822 and Wilding, J ORCID: 0000-0003-2839-8404
(2017)
Compensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes mellitus: A randomised double-blind, placebo-controlled, cross-over trial (ENERGIZE)- study protocol.
BMJ Open, 7 (1).
e013539-.
Wilding, J ORCID: 0000-0003-2839-8404, Bailey, C, Rigney, U, Blak, B, Kok, M and Emmas, C
(2017)
Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up.
PRIMARY CARE DIABETES, 11 (5).
pp. 437-444.
Wilding, J ORCID: 0000-0003-2839-8404, Zourikian, N, Di Minno, M, Khair, K, Marquardt, N, Benson, G, Ozelo, M and Hermans, C
(2018)
Obesity in the global haemophilia population: prevalence, implications and expert opinions for weight management.
OBESITY REVIEWS, 19 (11).
pp. 1569-1584.
Psarou, A
(2017)
Type 2 diabetes patients and their body weight: A mixed methods study investigating beliefs, attitudes, and adherence to their medicines over time.
PhD thesis, University of Liverpool.
Bing, C, Ding, C and Wilding, J ORCID: 0000-0003-2839-8404
(2016)
Vitamin D3 analogues ZK159222 and Zk191784 have anti-inflammatory properties in human adipocytes.
Endocrinology, Metabolsim & Genetics, 1 (1).
Cuthbertson, D ORCID: 0000-0002-6128-0822, Steele, T, Wilding, J ORCID: 0000-0003-2839-8404, Halford, JCG ORCID: 0000-0003-1629-3189, Harrold, JA ORCID: 0000-0002-0899-4586, Hamer, M and Karpe, F
(2017)
What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications?
International Journal of Obesity, 41 (6).
pp. 853-865.